Key Market Indicators
Icelander Beta Blocking Medicine Sales are expected to reach $3.84 million by 2026. In 2021, the market was valued at $3.63 million – a growth of 1.3 percent annually since 1994. Iceland is ranked 25th in 2021, with Luxembourg overtaking them at $3.63 million. Italy, Canada and Australia are placed second, third and fourth, respectively.
